美国时间4月10日,美国食品药品监督管理局(FDA)官网更新了一则具有里程碑意义的政策调整:计划逐步取消在单克隆抗体疗法和其他药物研发中对动物实验的强制性要求。 实际上,2022年FDA就通过了《FDA现代化法案2.0》,提倡寻找动物实验的替代方案,但最新政策更加具体,指明了智能计算模型、类器官与器官芯片、跨物种数据整合的三大替代方向。上述计划发布后立刻引发了医药行业的震动,由于对动物实验更为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.